Jan'05 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | $1.1 | $1.5 | $1.7 | $2.0 | $2.2 | $2.6 | $2.5 | $2.6 | $3.1 | $3.8 | $4.0 | $4.7 | $4.9 | $6.5 | ($0.6) | $5.1 | $5.5 | $6.0 | $3.3 | $6.5 |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, CVS Health Corporation's last 12-month EPS is $3.9, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, CVS Health Corporation's EPS growth was (40.9%). The average annual EPS growth rates for CVS Health Corporation have been (11.1%) over the past three years, 3.2% over the past five years.
Over the last year, CVS Health Corporation's EPS growth was (40.9%), which is lower than industry growth of (0.1%). It indicates that CVS Health Corporation's EPS growth is Bad.